• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

So how about that IMO town hall


<



And skips the question about a potential marketing reorganization. It’s so clearly going to happen, and we’ll be back in the TA model soon enough. The “centers of excellence” model is creating more problems than it’s solving… and wtf is content lab
 




And skips the question about a potential marketing reorganization. It’s so clearly going to happen, and we’ll be back in the TA model soon enough. The “centers of excellence” model is creating more problems than it’s solving… and wtf is content lab
A bunch of people with no pharma experience trying to "teach" best practices in this highly regulated environment
 
















Similar threads

Replies
9
Views
891
Replies
19
Views
2K
Novartis
anonymous
Replies
72
Views
8K
Novartis
anonymous